West Pharmaceutical Services, Inc. is a leading manufacturer of containment and delivery systems for injectable drugs and healthcare products, operating primarily in the United States, Europe, and internationally. The company is structured into two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment, which accounts for around 80% of revenue, provides a range of components such as stoppers, seals, and syringe and cartridge solutions, along with advanced administration systems designed to enhance drug delivery. This segment also offers integrated solutions, including analytical lab services and regulatory expertise, catering to pharmaceutical and biopharmaceutical companies. The Contract-Manufactured Products segment focuses on designing and assembling components for drug delivery systems and consumer products, serving various medical and diagnostic firms. Approximately 55% of West's revenue is generated from international markets, highlighting its global reach. Founded in 1923 and headquartered in Exton, Pennsylvania, West Pharmaceutical Services is recognized for its innovative solutions that improve the safety and efficacy of drug delivery.
Vice President and General Manager of Emerging Markets
Fernando Mateos Sutcliffe
CEO
5 past transactions
Pharma Latch
Corporate Round in 2022
Pharma Latch, a subsidiary of Latch Medical, specializes in innovative drug and vaccine delivery systems that utilize advanced microneedle technology. This approach allows for intradermal delivery, meaning that medications can be administered directly into the skin, enhancing patient comfort and experience. The company has developed a tissue anchor system featuring opposing arrays of angled microneedles, which painlessly penetrate the skin while ensuring consistent delivery depth. This technology aims to improve the effectiveness of drug and vaccine administration and provides healthcare professionals with better alternatives for wound management. Through its core platform technology, Pharma Latch is positioned to make significant advancements in the field of medical delivery systems.
Plastef Investissements - Drug Delivery Assets
Acquisition in 2009
Plastef Investissements SA. Under the agreement West has obtained the right to manufacture the eris safety syringe.
Medimop Medical Projects
Acquisition in 2005
Medimop Medical Projects Ltd. develops and manufactures devices for mixing, transferring, reconstituting, and administering.
Tech Group North America
Acquisition in 2005
Tech Group North America, Inc. offers contract manufacturing services to pharmaceutical, medical, and consumer industries.
Monarch Analytical Labs
Acquisition in 2005
Monarch Analytical Labs Inc is an Environmental Services company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.